Impact of locoregional treatment intensification in stampede high-risk M0 prostate cancer patients is a research paper published in Brachytherapy (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: P30CA042014
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
MeSH Terms
Keywords